Download PDF
1 / Pages

Other users also viewed these articles

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis Luis Vega; Daniela Simian; Abraham I. Gajardo; Marcelo Salinas; Andrea Urra; Máximo Cattaneo; Rosario Pino; Juan P. Roblero; Álvaro Urzúa; Katherine Rojas; Jaime Poniachik;
10.1016/j.aohep.2024.101511
P-11 PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS HEPATIC OVERLAP SYNDROME ¿ CASE REVIEW Federico Aronsohn; Jaime Poniachik; Álvaro Urzúa;
Ann Hepatol. 2024;29 Supl 1:
O-16 DIFFERENCES IN HEPATOCARCINOMA IN PATIENTS WITH CIRRHOSIS DUE TO NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) VS. OTHER ETIOLOGIES Jimmy Sanga; Daniela Simian; Federico Aronsohn; Jaime Poniachik;
Ann Hepatol. 2024;29 Supl 1: